COMP <GO>
ISPR vs MRK // ENTERPRISE SCALE & MARKET CAP
Ispire Technology Inc. (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: ISPR 0
— MRK 11
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MRK
LAST: $1.37 (-1.44%) • MKT CAP: $79.1M
market-cap
$79.1M
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
market-cap
$361.02B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ISPR VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ISPR | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 17.80% | 74.80% | -57.00 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 20.70% | -55.70 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -10.71% | 3.42% | -14.13 | MRK | /fcf-yield <GO> |
| Operating Margin | -29.70% | 34.30% | -64.00 | MRK | /operating-margins <GO> |
| Net Profit Margin | -30.80% | 28.10% | -58.90 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -16.10% | 1.30% | -17.40 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.19 | -4.99 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 7/9 | -5.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.9 | 51.7 | -2.80 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $79.1M | $361.02B | -$360.94B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ISPR REV | MRK REV | ISPR GROSS % | MRK GROSS % | ISPR FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $127.5M | $65.01B | 17.8% | 74.8% | -$8.5M | $12.36B |
| FY 2024 | $151.9M | $64.17B | 19.6% | 76.3% | -$20.3M | $18.10B |
| FY 2023 | $115.6M | $60.12B | — | — | -$8.5M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ISPR // BETA —
MRK // BETA 0.92